Cancerous 'floater': A lesson learned about tissue identity testing, endometrial cancer and microsatellite instability

Modern Pathology

Volumn 26, Issue 9, 2013, Pages 1264-1269

  Bossuyt, Veerle ^a   Buza, Natalia ^a   Ngo, Nhu T ^a   Much, Melissa A ^a   Asis, Maria C ^a   Schwartz, Peter E ^a   Hui, Pei ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

malignancy; MSI; tissue identity testing

Indexed keywords

GENOMIC DNA;

ADULT; ARTICLE; CANCER STAGING; CASE REPORT; CURETTAGE; DNA POLYMORPHISM; EARLY CANCER; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; PAPANICOLAOU TEST; PRIORITY JOURNAL; SHORT TANDEM REPEAT; TISSUE SECTION;

CARCINOMA, ENDOMETRIOID; CELL DIFFERENTIATION; CURETTAGE; DIAGNOSTIC ERRORS; ENDOMETRIAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; MIDDLE AGED; NEOPLASM STAGING; PHENOTYPE; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL; VAGINAL SMEARS;

EID: 84883857872     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2013.63     Document Type: Article

References (13)

1. Hunt JL, Swalsky P, Sasatomi E, et al. A microdissection and molecular genotyping assay to confirm the identity of tissue floaters in paraffin-embedded tissue blocks. Arch Pathol Lab Med 2003;127:213-217. (Pubitemid 36231770)
2. Tsongalis GJ, Berman MM. Application of forensic identity testing in a clinical setting: specimen identification. Diagn Mol Pathol 1997;6:111-114. (Pubitemid 27155032)
3. Lipata F, Parkash V, Talmor M, et al. Precise DNA genotyping diagnosis of hydatidiform mole. Obstet Gynecol 2010;115:784-794.
4. Berg KD, Glaser CL, Thompson RE, et al. Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction. J Mol Diagn 2000;2:20-28.
5. Zhivotovsky LA, Bennett L, Bowcock AM, et al. Human population expansion and microsatellite variation. Mol Biol Evol 2000;17:757-767. (Pubitemid 30252263)
6. Greenson JK, Bonner JD, Ben-Yzhak O, et al. Phenotype of microsatellite unstable colorectal carcinomas: well-differentiated and focally mucinous tumors and the absence of dirty necrosis correlate with microsatellite instability. Am J Surg Pathol 2003;27:563-570. (Pubitemid 36514468)
7. Meyer LA, Broaddus RR, Lu KH. Endometrial cancer and Lynch syndrome: clinical and pathologic considerations. Cancer Control 2009;16:14-22.
8. Vasen HF, Stormorken A, Menko FH, et al. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol 2001;19:4074-4080. (Pubitemid 32976695)
9. Hampel H, Stephens JA, Pukkala E, et al. Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Gastroenterology 2005;129:415-421. (Pubitemid 41096629)
10. Stoffel EM, Ford B, Mercado RC, et al. Sharing genetic test results in Lynch syndrome: communication with close and distant relatives. Clin Gastroenterol Hepatol 2008;6:333-338.
11. Lu KH, Broaddus RR. Gynecologic Cancers in Lynch Syndrome/HNPCC. Fam Cancer 2005;4:249-254. (Pubitemid 41242195)
12. Lanspa SJ, Jenkins JX, Cavalieri RJ, et al. Surveillance in Lynch syndrome: how aggressive? Am J Gastroenterol 1994;89:1978-1980. (Pubitemid 24334236)
13. Matthews KS, Estes JM, Conner MG, et al. Lynch syndrome in women less than 50 years of age with endometrial cancer. Obstet Gynecol 2008;111: 1161-1166. (Pubitemid 351620352)